KARPAS 417

NOTE: Both the cell line and DNA from the cell line may be available for this product. Please choose -1VL or VIAL for cells, or -DNA-5UG for DNA.

• Synonym(e): KARPAS, 417
• UNSPSC Code: 41106514
• Biological source: human blood
• Relevant disease(s): cancer
• Growth mode: Suspension
• Karyotype: Complex translocations, refer to Karpas et al., 2005
• Morphology: Single round to polymorphic cells growing in suspension

Eigenschaften

• biological source: human blood
• packaging: tube of 5 μg 06100302-DNA-5UG, pkg of vial of cells 06100302-1VL
• growth mode: Suspension
• karyotype: Complex translocations, refer to Karpas et al., 2005
• morphology: Single round to polymorphic cells growing in suspension
• products: Secretes IgGks
• receptors: Not specified
• technique(s): cell culture | mammalian: suitable
• relevant disease(s): cancer
• shipped in: dry ice
• storage temp.: -140 to -196°C

Beschreibung

Biochem/physiol Actions

Established from the peripheral blood of a 56 year-old male diagnosed with multiple myeloma.

Human myeloma

Not specified

Preparation Note

Maintain cultures between 0.5 - 2 x 1000,000 cells/ml; 5% CO₂; 37 °C. Doubling time approximately 60 hours. Split saturated culture 1:2 every 2-4 days. Round to polymorhpic cells growing singly or in small clusters in suspension.

RPMI 1640 + 2 mM Glutamine + 10% Fetal Bovine Serum (FBS).

Other Notes

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). Use of this product by commercial organizations may require a license agreement. Commercial customers will be contacted by [email protected] to provide further information after the order request is submitted. Any other use of these products is prohibited without the express written permission of UKHSA. Inquiries regarding authorized use of this cell line or its genomic DNA may be directed to [email protected].

Disclaimer

This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form.